CRMD
CorMedix Inc. Healthcare - Biotechnology Investor Relations →
CorMedix Inc. (CRMD) closed at $7.69 as of 2026-02-02, trading 18.6% above its 200-week moving average of $6.48. The stock is currently moving closer to the line, down from 19.9% last week. The 14-week RSI sits at 36, indicating neutral momentum.
Over the past 773 weeks of data, CRMD has crossed below its 200-week moving average 17 times. On average, these episodes lasted 28 weeks. The average one-year return after crossing below was -3.9%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $606 million, CRMD is a small-cap stock. The company generates a free cash flow yield of 2.8%. Return on equity stands at 75.1%, indicating strong profitability. The stock trades at 1.6x book value.
Share count has increased 69.1% over three years, indicating dilution. CRMD passes our Buffett quality screen: high return on equity, low debt, and positive free cash flow.
Over the past 14.9 years, a hypothetical investment of $100 in CRMD would have grown to $82, compared to $659 for the S&P 500. CRMD has returned -1.3% annualized vs 13.5% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: CRMD vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After CRMD Crosses Below the Line?
Across 17 historical episodes, buying CRMD when it crossed below its 200-week moving average produced an average return of -7.2% after 12 months (median -25.0%), compared to +13.1% for the S&P 500 over the same periods. 29% of those episodes were profitable after one year. After 24 months, the average return was -31.3% vs +32.2% for the index.
Each line shows $100 invested at the moment CRMD crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
CRMD has crossed below its 200-week MA 17 times with an average 1-year return of +-3.9% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Apr 2011 | Apr 2011 | 1 | 0.8% | -79.5% | -12.6% |
| May 2011 | Dec 2013 | 137 | 85.1% | -82.9% | -9.5% |
| Dec 2015 | Dec 2015 | 1 | 2.1% | -5.4% | -16.4% |
| Jan 2016 | Feb 2016 | 8 | 35.7% | +6.1% | -6.8% |
| Jun 2016 | Sep 2016 | 14 | 32.9% | -80.0% | -28.5% |
| Oct 2016 | Jan 2019 | 120 | 91.8% | -72.2% | -33.1% |
| Feb 2019 | Feb 2019 | 1 | 1.1% | -25.4% | -9.0% |
| May 2019 | Jun 2019 | 3 | 10.6% | -36.3% | +11.8% |
| Sep 2019 | Dec 2019 | 11 | 22.0% | -22.2% | +15.1% |
| Jan 2020 | Feb 2020 | 1 | 0.2% | +37.8% | +21.1% |
| Feb 2020 | Jun 2020 | 14 | 54.2% | +188.5% | +47.9% |
| Jul 2020 | Sep 2020 | 8 | 24.0% | +30.6% | +72.8% |
| Oct 2020 | Nov 2020 | 1 | 1.5% | -3.8% | +52.3% |
| Jul 2021 | Aug 2021 | 1 | 0.5% | -7.9% | +32.4% |
| Aug 2021 | Aug 2021 | 1 | 0.2% | -33.4% | +31.0% |
| Sep 2021 | Apr 2024 | 135 | 56.2% | -19.7% | +66.1% |
| May 2024 | Aug 2024 | 14 | 25.7% | +139.8% | +50.2% |
| Average | 28 | — | +-3.9% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02